Data as of Mar 11
| +0.07 / +0.11%|
The 30 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 59.21, with a high estimate of 75.10 and a low estimate of 45.01. The median estimate represents a -11.24% decrease from the last price of 66.71.
The current consensus among 31 polled investment analysts is to Hold stock in AstraZeneca PLC. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.